Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X)

NCT04768062 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Duchenne Muscular Dystrophy

Interventions

DRUG: Viltolarsen

Sponsor

NS Pharma, Inc.

Collaborators

[object Object]